Cahill LE, Warren RA, Carew AS, Levy AP, et al. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study. Diabetes Care 2024 Mar 14:dc232165. doi: 10.2337/dc23-2165.
PMID: 38484336